Gliwice

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma3 trials
• Head and neck cancer1 trial
• Thyroid cancer1 trial

Phase

• Phase 34 trials
• Phase 41 trial

Status

• Not yet recruiting2 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• AstraZeneca4 trials
• Sanofi1 trial

Running trials

• Recruiting

  A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).

  NCT07735637· Phase 3· AstraZeneca· Source

• Recruiting

  Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

  NCT07764978· Phase 3· AstraZeneca· Source

• Recruiting

  A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

  NCT07391657· Phase 3· AstraZeneca· Source

• Recruiting

  A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

  NCT06129864· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma3 recruiting
• Head and neck cancer1 recruiting

Closed trials

• Completed

  To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer

  NCT01496313· Phase 4· Sanofi· Source